Viewing Study NCT00768105


Ignite Creation Date: 2025-12-25 @ 3:15 AM
Ignite Modification Date: 2026-03-10 @ 11:50 PM
Study NCT ID: NCT00768105
Status: COMPLETED
Last Update Posted: 2010-12-03
First Post: 2008-10-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Insulin
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 2 diabetes View